105 related articles for article (PubMed ID: 2829053)
1. Synthesis and biological activity of N-methylated analogues of neurokinin A.
Rovero P; Pestellini V; Patacchini R; Santicioli P; Maggi CA; Meli A
Neuropeptides; 1987; 10(4):355-9. PubMed ID: 2829053
[TBL] [Abstract][Full Text] [Related]
2. A potent and selective agonist for NK-2 tachykinin receptor.
Rovero P; Pestellini V; Patacchini R; Giuliani S; Santicioli P; Maggi CA; Meli A; Giachetti A
Peptides; 1989; 10(3):593-5. PubMed ID: 2550911
[TBL] [Abstract][Full Text] [Related]
3. Dactinomycin is a competitive neurokinin-2 receptor antagonist.
Delay-Goyet P; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1342-9. PubMed ID: 1659413
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of substance P C-terminal hexapeptide and heptapeptide analogues.
Stavropoulos G; Karagiannis K; Cordopatis P; Halle D; Gilon C; Bar-Akiva G; Selinger Z; Chorev M
Int J Pept Protein Res; 1991 Mar; 37(3):180-4. PubMed ID: 1714423
[TBL] [Abstract][Full Text] [Related]
5. Peptide receptors in the airways.
Regoli D
Am Rev Respir Dis; 1987 Dec; 136(6 Pt 2):S35-9. PubMed ID: 2446539
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin receptor subtypes characterized by biological assays.
Regoli D; Nguyen QT; Jukic D
Life Sci; 1994; 54(26):2035-47. PubMed ID: 8208061
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of dimeric analogs of neurokinin A and B: effect of dimerization of COOH-terminal heptapeptides on receptor selection.
Sakaguchi K; Kodama H; Matsumoto H; Yoshida M; Takano Y; Kamiya H; Waki M; Shimohigashi Y
Pept Res; 1989; 2(5):345-51. PubMed ID: 2485210
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of neurokinin A.
Rovero P; Pestellini V; Rhaleb NE; Dion S; Rouissi N; Tousignant C; Télémaque S; Drapeau G; Regoli D
Neuropeptides; 1989; 13(4):263-70. PubMed ID: 2546091
[TBL] [Abstract][Full Text] [Related]
9. Desensitization with a selective agonist discriminates between multiple tachykinin receptors.
Laufer R; Gilon C; Chorev M; Selinger Z
J Pharmacol Exp Ther; 1988 May; 245(2):639-43. PubMed ID: 2835478
[TBL] [Abstract][Full Text] [Related]
10. Relative potencies of neurokinins in guinea pig trachea and human bronchus.
Advenier C; Naline E; Drapeau G; Regoli D
Eur J Pharmacol; 1987 Jul; 139(2):133-7. PubMed ID: 2888665
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
Munekata E; Kubo K; Tanaka H; Osakada F
Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
[TBL] [Abstract][Full Text] [Related]
12. The contractile activities of neurokinin A, B and related peptides on smooth muscles.
Osakada F; Kubo K; Goto K; Kanazawa I; Munekata E
Eur J Pharmacol; 1986 Jan; 120(2):201-8. PubMed ID: 2419146
[TBL] [Abstract][Full Text] [Related]
13. Pseudopeptide analogues of substance P and leucine enkephalinamide containing the psi (CH2O) modification: synthesis and biological activity.
Roubini E; Laufer R; Gilon C; Selinger Z; Roques BP; Chorev M
J Med Chem; 1991 Aug; 34(8):2430-8. PubMed ID: 1714957
[TBL] [Abstract][Full Text] [Related]
14. Dimerization of neurokinin A and B COOH-terminal heptapeptide fragments enhanced the selectivity for tachykinin receptor subtypes.
Kodama H; Shimohigashi Y; Sakaguchi K; Waki M; Takano Y; Yamada A; Hatae Y; Kamiya H
Eur J Pharmacol; 1988 Jul; 151(2):317-20. PubMed ID: 2844557
[TBL] [Abstract][Full Text] [Related]
15. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
16. Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides.
Maggi CA; Patacchini R; Santicioli P; Giuliani S; Turini D; Barbanti G; Giachetti A; Meli A
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):256-61. PubMed ID: 1692976
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated specific biological activity of a beta-amyloid protein fragment for NK-1 substance P receptors.
Shimohigashi Y; Matsumoto H; Takano Y; Saito R; Iwata T; Kamiya H; Ohno M
Biochem Biophys Res Commun; 1993 Jun; 193(2):624-30. PubMed ID: 7685598
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin antagonist I: Specific, competitive and tissue-selective neurokinin B antagonists on contractile activity in smooth muscles.
Hashimoto T; Uchida Y; Naminohira S; Sakai T
Jpn J Pharmacol; 1987 Dec; 45(4):570-3. PubMed ID: 3481842
[TBL] [Abstract][Full Text] [Related]
20. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
Morimoto H; Murai M; Maeda Y; Yamaoka M; Nishikawa M; Kiyotoh S; Fujii T
J Pharmacol Exp Ther; 1992 Jul; 262(1):398-402. PubMed ID: 1378096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
